The T1R2/T1R3 sweet receptor and TRPM5 ion channel: Taste targets with therapeutic potential

Progress in Molecular Biology and Translational Science

Volumn 91, Issue C, 2010, Pages 151-208

  Sprous, Dennis ^a   Palmer, R Kyle ^a  

^a Redpoint Bio Corporation   (United States)

Author keywords

Chemoinformatics; Drug discovery; Gastrointestinal; Ion channel; Sweet receptor; T1R2 T1R3; Taste signaling; TRPM5

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND; SWEETENING AGENT; TASTE RECEPTORS, TYPE 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM5 PROTEIN, HUMAN;

ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DIABETES MELLITUS; DRUG DEVELOPMENT; DRUG EFFECT; HUMAN; OBESITY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TASTE BUD;

ANIMALS; DIABETES MELLITUS; DRUG DISCOVERY; HUMANS; LIGANDS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SWEETENING AGENTS; TASTE BUDS; TRPM CATION CHANNELS;

EID: 77957261430     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(10)91006-5     Document Type: Chapter

References (210)

1. Society for the Study of Ingestive Behavior Society for the Study of Ingestive Behavior http://www.ssib.org/web 2010 Last accessed 12-Feb-2010
2. R.P. Nair, and J. Ren Pharmacotherapy of obesitybenefits, bias and hyperbole Curr Med Chem 16 2009 1888 1897
3. R.K. Palmer The pharmacology and signaling of bittr, sweet, and umami taste sensing Mol Interv 7 2007 87 98
4. X. Li, and G. Servant Functional characterization of the human sweet receptor: high-throughput screening assay development and structural function relation D.K. Weerasinghe, G.E. Dubois, Sweetness and sweeteners: biology, chemistry and psychophysics 979 2008 Oxford University Press Washington, USA 368 385
5. F. Zhang, B. Klebansky, R.M. Fine, H. Xu, A. Pronin, and H. Liu Molecular mechanism for the umami taste synergism Proc Natl Acad Sci USA 105 2008 20930 20934
6. Y. Zhang, M. Hoon, J. Chandrashekar, K. Mueller, B. Cook, and D. Wu Coding of sweet, bitter, and umami tastes, different receptor cells sharing similar signaling pathways Cell 112 2003 293 301 (Pubitemid 36183651)
7. Center for Disease Control and Prevention Obesity and overweight for professionals http://www.cdc.gov/obesity/data/trends.html 2010 Last accessed 12-Feb-2010
8. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, and V.S. Bales Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 2003 76 79 (Pubitemid 36026281)
9. B.M. Popkin, S.J. Nielsen, and A.M. Siega-Riz Trends in energy intake in U.S. between 1977 and 1996: similar shifts seen across age groups Obes Res 10 2002 370 378
10. I.H. Steenhuis, and W.M. Vermeer Portion size: review and framework for interventions Int J Behav Nutr Phys Act 6 2009 58
11. V.S. Malik, M.B. Schulze, and F.B. Hu Intake of sugar-sweetened beverages and weight gain: a systematic review Am J Clin Nutr 84 2006 274 288
12. A. Bellisari Evolutionary origins of obesity Obes Rev 9 2008 165 180 (Pubitemid 351197435)
13. J. Glendinning, and A. Spector A high-throughput screening procedure for identifying mice with aberrant taste and oromotor function Chem Senses 27 2002 461 474 (Pubitemid 34693006)
14. G.H. Collier Satiety: an ecological perspective Brain Res Bull 14 1985 693 700
15. J.A. Ello-Martin, J.H. Ledikwe, and B.J. Rolls The influence of food portion size and energy density on energy intake: implications for weight management Am J Clin Nutr 82 1 Suppl. 2005 S236 41
16. L.S. Lieberman Evolutionary and anthropological perspectives on optimal foraging in obesogenic environments Appetite 47 1 2006 3 9
17. B.M. Popkin, and S.J. Nielsen The sweetening of the world's diet Obes Res 11 2003 1325 1332
18. K.D. Brownell, T. Farley, W.C. Willett, B.M. Popkin, F.J. Chaloupka, and J.W. Thompson The public health and economic benefits of taxing sugar-sweetened beverages N Engl J Med 361 2009 1599 1605
19. J. Putnam, J. Allshouse, and L.S. Kantor U.S. per capita food supply trends: more calories, refined carbohydrates, and fats Economic Research Service, USDA, Food Rev 25 Issue 3 2002 2 15
20. J.S. White Straight talk about high-fructose corn syrup: what it is and what it ain't Am J Clin Nutr 88 2008 236S1716 21
21. K.J. Duffy, and B.M. Popkin High-fructose corn syrup: is this what's for dinner? Am J Clin Nutr 88 2008 S1722 32
22. G.A. Bray Fructose: should we worry? Int J Obes 32 2008 S127 S131
23. P. Sharon, S.P. Fowler, K. Ken Williams, R.G. Resendez, J. Kelly, and K.J. Hunt Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain Obesity 16 2008 1894 1900
24. F. Bellisle, and A. Drewnowski Intense sweeteners, energy intake and the control of body weight Eur J Clin Nutr 61 2007 691 700 (Pubitemid 47232348)
25. S.E. Swithers, and T.L. Davidson A role for sweet taste: calorie predictive relations in energy regulation by rats Behav Neurosci 122 2008 161 173
26. S.E. Swithers, C.R. Baker, and T.L. Davidson General and persistent effects of high intensity sweeteners on body weight gain and caloric comensation in rats Behav Neurosci 123 2009 772 780
27. J.M. Egan, and R.F. Margolskee Taste cells of the gut and gastrointestinal chemosensation Mol Interv 8 2008 78 81
28. E. Rozengurt, and C. Sternini Taste receptor signaling in the mammalian gut Curr Opin Pharmacol 7 2007 557 562 (Pubitemid 350185856)
29. C. Sternini, L. Anselmi, and E. Rozengurt Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing Curr Opin Endocrinol Diab Obes 15 2008 73 78
30. D.E. Grigoriadis, S.R.J. Hoare, S.M. Lechner, D.H. Slee, and J.A. Williams Drugability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels Neuropsychopharmacology 34 2009 106 125
31. R.W. Bryant, K.S. Atwal, I. Bakaj, M.T. Buber, S. Carlucci, and R. Cerne Development of transient receptor potential melanostatin 5 modulators for sweetness enhancement D.K. Weerasinghe, G.E. Dubois, Sweetness and sweeteners: biology, chemistry and psychophysics 979 2008 Oxford University Press Washington, USA 386 399
32. G. Nelson, M.A. Hoon, J. Chandrashekar, Y. Zhang, N.J. Ryba, and C.S. Zuker Mammalian sweet taste receptors Cell 106 2001 381 390 (Pubitemid 32772621)
33. P.A. Temussi The sweet taste receptor: a single receptor with multiple sites and modes of interaction Adv Food Nutr Res 53 2007 199 239
34. M. Cui, P. Jiang, E. Maillet, M. Max, R.F. Margolskee, and R. Osman The heterodimeric sweet taste receptor has multiple potential ligand binding sites Curr Pharm Des 12 2006 4591 4600 (Pubitemid 44835147)
35. G.W. Muller, D.E. Walters, and G.E. DuBois N, N'-disubstituted guanidine high-potency sweeteners J Med Chem 35 1992 740 743
36. G. Zhao, Y. Zhang, M. Hoon, J. Chandrashekar, I. Erlenbach, and N. Ryba The receptors for mammalian sweet and umami taste Cell 115 2003 255 266 (Pubitemid 37487700)
37. P. Jiang, Q. Ji, Z. Liu, L. Snyder, L. Bernard, and R. Margolskee The cysteine-rich region of the T1R3 determines responses to intensely sweet proteins J Biol Chem 279 2004 45068 45075 (Pubitemid 39430921)
38. H. Xu, L. Staszewski, H. Tang, E. Adler, M. Zoller, and X. Li Different functional roles of T1R subunits in the heteromeric taste receptors Proc Natl Acad Sci USA 101 2004 14258 14263 (Pubitemid 39305062)
39. Y. Nie, S. Vigues, J. Hobbs, G. Conn, and S. Munger Distinct contributions of T1R2 and T1R3 taste receptor taste receptor subunits to the detection of sweet stimuli Curr Biol 15 2005 1948 1952 (Pubitemid 41566143)
40. P.A. Temussi Sweet, bitter and umami receptors Trends Biochem Sci 6 2009 296 302
41. G. Morini, A. Bassoli, and P.A. Temussi From small sweeteners to sweet proteins: anatomy of the binding sites of the human T1R2T1R3 receptor J Med Chem 48 2005 5520 5529 (Pubitemid 41209249)
42. S.S. Schiffman, B.J. Booth, B.T. Carr, M.L. Losee, E.A. Sattely-Miller, and B.G. Graham Investigation of synergism in a binary mixture of sweeteners Brain Res Bull 38 1995 105 120
43. S.D. Roper Signal transduction and information processing in mammalian taste buds Pflugers Arch 454 2007 759 776
44. J. Dyer, K.S.H. Salmon, L. Zibrik, and S.P. Shirazi-Beechey Expression of sweet taste receptors of the T1R family in the intestinal tract and enteroendocrine cells Biochem Soc Trans 33 2005 302 305 (Pubitemid 40313828)
45. O.J. Mace, J. Affleck, N. Patel, and G.L. Kellett Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2 J Physiol 582 2007 379 392 (Pubitemid 46993582)
46. C. Bezenon, A. Frholz, F. Raymond, R. Mansourian, S. Mtairon, and J. Le Coutre Murine intestinal cells expressing Trpm5 are mostly brush cells and express markers of neuronal and inflammatory cells J Comp Neurol 509 2008 514 525
47. R.L. Young, K. Sutherland, N. Pezos, S.M. Brierley, M. Horowitz, and C.K. Rayner Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes Gut 58 2009 337 346
48. R.F. Margolskee, J. Dyer, Z. Kokrashvili, K.S.H. Salmon, E. Ilegems, and K. Daly T1R3 and gustducin in gut sense sugars to regulate expression of Na-glucose cotransporter 1 Proc Natl Acad Sci USA 104 2007 15075 15080 (Pubitemid 47619595)
49. H.J. Jang, Z. Kokrashvili, M.J. Theodorakis, O.D. Carlson, B.J. Kim, and J. Zhou Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 Proc Natl Acad Sci USA 104 2007 15069 15074 (Pubitemid 47619594)
50. C. Bezencon, J. le Coutre, and S. Damak Taste-signaling proteins are coexpressed in solitary intestinal epithelial cells Chem Senses 32 2007 41 49 (Pubitemid 46017873)
51. N. Damann, T. Voets, and B. Nilius TRPs in our senses Curr Biol 18 2008 R880 R889
52. B. Nilius, G. Owsianik, T. Voets, and J.A. Peters Transient receptor potential cation channels in disease Physiol Rev 87 2007 165 217 (Pubitemid 46207713)
53. R. Gaudet TRP channels entering the structural era J Physiol 586 2008 3565 3575
54. A. Fleig, and Penner R. Trends The TRPM ion channel subfamily: molecular, biophysical and functional features Pharmacol Sci 25 2004 633 639 (Pubitemid 39458169)
55. L.-H. Jiang Subunit interaction in channel assembly and functional regulation of transient receptor potential melastatin (TRPM) channels Biochem Soc Trans 35 2007 86 88 (Pubitemid 46271816)
56. i Proc Natl Acad Sci USA 100 2003 15166 15171 (Pubitemid 37518034)
57. 2+ -activated monovalent selective cation channel Curr Biol 13 2003 1153 1158 (Pubitemid 36815266)
58. D. Liu, and E. Liman Intracellular Ca2+ and the phospholipid PIP2 regulate the taste transduction ion channel TRPM5 Proc Natl Acad Sci USA 100 2003 15160 15165 (Pubitemid 37518033)
59. C. Perez, L. Huang, M. Rong, J. Kozak, A. Preuss, and H. Zhang Transient receptor potential channel in taste receptor cells Nat Neurosci 5 2002 1169 1176 (Pubitemid 35247176)
60. R. DeFazio, G. Dvoryanchikov, Y. Maruyama, J. Kim, E. Pereira, and S. Roper Separate populations of receptor cells and presysnaptic cells in mouse taste buds J Neurosci 26 2006 971 3980 (Pubitemid 44315417)
61. E. Fonfria, P. Murdock, F. Cusdin, C. Benham, R. Kelsell, and S. McNulty Tissue distribution profiles of the human TRPM cation channel family J Recept Signal Transduct Res 26 2006 159 178
62. 2+ channels Am J Physiol Cell Physiol 291 2006 C726 C739 (Pubitemid 44497598)
63. T.R. Clapp, K.F. Medler, S. Damak, R.F. Margolskee, and S.C. Kinnamon Mouse taste cells with G protein-coupled taste receptors lack voltage-gated calcium channels and SNAP-25 BMC Biol 4 2006 7 16
64. N. Gao, M. Lu, F. Echeverri, B. Laita, D. Kalabat, and M.E. Williams Voltage-gated sodium channels in taste bud cells BMC Neurosci 10 2009 20
65. R. Romanov, and S. Kolesnikov Electrophysiologically identified subpopulations of taste bud cells Neurosci Lett 395 2006 249 254 (Pubitemid 43213155)
66. E. Sainz, M.M. Cavenagh, N.D. LopezJimenez, J.C. Gutierrez, J.F. Battey, and J.K. Northup The G-protein coupling properties of the human sweet and amino acid taste receptors Dev Neurobiol 67 2007 948 959 (Pubitemid 47078856)
67. D.A. Yarmolinsky, C.S. Zuker, and N.J. Ryba Common sense about taste: from mammals to insects Cell 139 2009 234 244
68. Y. Huang, Y. Maruyama, G. Dvoryanchikov, E. Pereira, N. Chaudhari, and S. Roper The role of pannexin-1 hemichannels in ATP release and cell-cell communication in mouse taste buds Proc Natl Acad Sci USA 104 2007 6436 6441 (Pubitemid 47186112)
69. G. Tolhurst, F. Reimann, and F.M. Gribble Nutritional regulation of glucagon-like peptide-1 secretion J Physiol 587 2009 27 32
70. A. Sbarbati, and F. Osculati A new fate for old cells: brush cells and related elements J Anat 206 2005 349 358 (Pubitemid 40542840)
71. Z. Kokrashvili, D. Rodriguez, V. Yevshayeva, H. Zhou, and R.F. Margolskee Release of endogenous opioids from duodenal enteroendocrine cells requires TrpM5 Gastroenterology 137 2009 598 606
72. W. Kim, and J.M. Egan The role of incretins in glucose homeostasis and diabetes treatment Pharmacol Rev 60 2008 470 512
73. B.R. Gauthier, and C.B. Wollheim Synaptotagmins bind calcium to release insulin Am J Physiol Endocrinol Metab 295 2008 E1279 E1286
74. R. Bertram, A. Sherman, and L.S. Satin Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion Am J Physiol Endocrinol Metab 293 2007 E890 E900 (Pubitemid 47535819)
75. F. Reimann, A.M. Habib, G. Tolhurst, H.E. Parker, G.J. Rogers, and F.M. Gribble Glucose sensing in L cells: a primary cell study Cell Metab 8 2008 532 539
76. F. Reimann, and F.M. Gribble Glucose-sensing in glucagon-like peptide-1secreting cells Diabetes 51 2002 2757 2763
77. B. Thorens GLUT2 in pancreatic and extra-pancreatic gluco-detection (review) Mol Membr Biol 18 2001 265 273 (Pubitemid 34052686)
78. J.C. Henquin Regulation of insulin secretion: a matter of phase control and amplitude modulation Diabetologia 52 2009 739 751
79. F.M. Gribble, L. Williams, A.K. Simpson, and F. Reimann A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line Diabetes 52 2003 1147 1154 (Pubitemid 36523349)
80. A. Hirasawa, K. Tsumaya, T. Awaji, S. Katsuma, T. Adachi, and M. Yamada Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat Med 11 2005 90 94 (Pubitemid 40215843)
81. H.A. Overton, A.J. Babbs, S.M. Doel, M.C. Fyfe, L.S. Gardner, and G. Griffin Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents Cell Metab 3 2006 167 175 (Pubitemid 43316522)
82. H.A. Overton, M.C.T. Fyfe, and C. Reynet GPR119, a novel G-protein-coupled receptor target for the treatment of type 2 diabetes and obesity Br J Pharmacol 153 2008 S76 S81 (Pubitemid 351340991)
83. F. Reimann, P.S. Ward, and F.M. Gribble Signalling mechanisms underlying the release of glucagon-like peptide-1 Diabetes 55 Suppl. 2 2006 S78 S85 (Pubitemid 44927036)
84. N. Rozengurt, S.V. Wu, M.C. Chen, C. Huang, C. Sternini, and E. Rozengurt Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon Am J Physiol Gastrointest Liver Physiol 291 2006 G792 G802 (Pubitemid 44772005)
85. K. Sutherland, R.L. Young, N.J. Cooper, M. Horowitz, and L.A. Blackshaw Phenotypic characterization of taste cells of the mouse small intestine Am J Physiol Gastrpomtest Liver Physiol 292 2007 G1420 G1428 (Pubitemid 47084658)
86. Z. Kokrashvili, B. Mosinger, and R.F. Margolskee Taste signaling elements expressed in gut enteroendocrine cells regulate nutrient-responsive secretion of gut hormones Am J Clin Nutr 90 2009 S822 5
87. American Dietetic Association Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners J Am Diet Assoc 104 2004 255 275 (Pubitemid 38183196)
88. V.L. Grotz, R.R. Henry, J.B. McGill, M.J. Prince, H. Shamoon, and J.R. Trout Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes J Am Diet Assoc 103 2003 1607 1612 (Pubitemid 38041191)
89. L.A. Barriocanal, M. Palacios, G. Benitez, S. Benitez, J.T. Jimenez, and N. Jimenez Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in type 1 and type 2 diabetics Regul Toxicol Pharmacol 51 2008 37 41
90. Y. Fujita, R.D. Wideman, M. Speck, A. Asadi, D.S. King, and T.D. Webber Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo Am J Physiol Endocrinol Metab 296 2009 E473 E479
91. J. Ma, M. Bellon, J.M. Wishart, R. Young, L.A. Blackshaw, and K.L. Jones Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects Am J Physiol Gastrointest Liver Physiol 296 2009 G735 G739
92. R. Vennekens, and B. Nilius Insights into TRPM4 function, regulation and a physiological role Handb Exp Pharmacol 179 2007 269 285
93. P. Launay, H. Cheng, S. Srivatsan, R. Penner, A. Fleig, and J.P. Kinet TRPM4 regulates calcium oscillations after T-cell activation Science 306 2004 1374 1377 (Pubitemid 39532514)
94. M.M. Winslow, and G.R. Crabtree Decoding calcium signaling Science 307 2005 56 57
95. M. Oh-hora, and A. Rao Calcium signaling in lymphocytes Curr Opin Immunol 20 2008 250 258
96. 2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5-/- mice Proc Natl Acad Sci USA 107 2010 5208 5213
97. P. Holzer Opioid receptors in the gastrointestinal tract Regul Pept 155 2009 11 17
98. S.K. Goyal, Samsher, and R.K. Goyal Stevia (Stevia rebaudiana) a bio-sweetener: a review Int J Food Sci Nutr 61 2010 1 10
99. J. Li, and J.C. Vederas Drug discovery and natural products: end of an era or an endless frontier? Science 325 2009 161 165
100. D.J. Long, F.X. Brennan, H.R. Devantier, R.W. Bryant, F.R. Salemme, and R.K. Palmer Development of a high throughput (HT) in vivo sweetness enhancing assay in rats Program No. 64.7. 2008 neuroscience meeting planner 2008 Society for Neuroscience Washington, DC [online]
101. D.E. Walters, F.T. Orthoefer, and G.E. DuBois Sweeteners: discovery, molecular design and chemoreception ACS Symposia Series 450 1990
102. N.K. Kim, and A.D. Kinghorn Highly sweet compounds of plant origin Arch Pharm Res 25 2002 725 746
103. D. Weininger SMILES. 1. Introduction and encoding rules J Chem Info Comp Sci 28 1988 31 38
104. Dragon Talete SRL 2009 Milan Italy
105. Molconn-z. Edusoft LLC: Ashland, VA, USA; 2009
106. MOE. Chemical Computing Group: Montreal, Canada; 2009
107. SYBYL. Tripos Inc.: St. Louis, MO, USA; 2009
108. ADAPT. Pennsylvania State University: College Station, PA USA; 2009
109. Codessa. Semichem Inc.: Shawnee Mission, KS, USA; 2009
110. W.L. Jorgensen QSAR/QSPR and proprietary data J Chem Inf Model 46 2006 3
111. D. Stanton, and P. Jurs Development and use of charged partial surface-area structural descriptors in computer-assisted quantitative structure-property relationship studies Anal Chem 62 1990 2323 2329
112. G. Cruciani, P. Crivori, P.-A. Carrupt, and B. Testa Molecular fields in quantitative structure permeation relationships: the VolSurf approach J Mol Struct 503 2000 17 30
113. A. Cherkasov Inductive descriptors Curr Comput Aided Drug Des 2005 2005 21 42
114. Almond Molecular discovery 2009 Pinner UK
115. R.D. Cramer III, D.E. Patterson, and J.D. Bunce Comparative molecular field analysis J Am Chem Soc 110 1988 5959 5967
116. G. Klebe, U. Abraham, and T. Mietzner Molecular similarity indexes in a comparative-analysis (CoMSIA) of drug molecules to correlate and predict their biological activity J Med Chem 37 1994 4130 4146 (Pubitemid 24379702)
117. S.A. Wildman, and G.M. Crippen Prediction of physiochemical parameters by atomic contributions J Chem Inf Comput Sci 39 1999 868 873
118. S.L. Dixon, and K.M. Mertz Jr. One-Dimensional molecular representations and similarity calculations: methodologies and validation J Med Chem 44 2001 3795 3809
119. L.H. Hall, and L.B. Kier Molecular connectivity in structure-activity analysis 1986 Wiley New York
120. L.B. Kier Inclusion of symmetry as a shape attribute in kappa-index analysis Quant Struct Activ Relat 6 1987 8 12 (Pubitemid 17072620)
121. L.B. Kier, and L.H. Hall Molecular structure description. The electrotopological state 1999 Academic Press New York
122. a by molecular tree structured fingerprints and PLS J Chem Comput Sci 43 2003 870 879
123. S. Rodgers, R.C. Glen, and A. Bender Characterizing bitterness J Chem Inf Model 46 2006 569 576
124. P. Ertle, B. Rohde, and P. Selzer Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its approach to the prediction of drug transport properties J Med Chem 43 2000 3714 3717
125. W. Zheng, and A. Tropsha Novel variable selection quantitative structure property relationship approach based on the k-nearestneighbor principle J Chem Inf Comput Sci 40 2000 185 194
126. J.L. Durant, B.A. Leland, D.R. Henry, and J.G. Nourse Reoptimization of MDL keys for use in drug discovery J Chem Inf Comput Sci 42 2002 1273 1280 (Pubitemid 35468313)
127. R.D. Brown, and Y.C. Martin An evaluation of structural descriptors and clustering methods for use in diversity selection SAR QSAR Environ Res 8 1998 23 39
128. Y.C. Martin, J.L. Kofron, and L.M. Traphagen Do structurally similar molecules have similar biological activities J Med Chem 45 2002 4350 4358
129. P. LaBute Binary QSAR: a new method for the determination of QSARs Pac Sym Biocomp 4 1999 444 445
130. R.D. Clark, D.G. Sprous, and J.M. Leonard Progressive scrambling H.-D. Holtje, W. Sippl, Rational approaches to drug design 2001 Prous Science S.A. Barcelona, Spain 475 486
131. A. Golbraik, and A. Tropsha Beware of q2 J Mol Graph Model 20 2002 269 276
132. A. Golbraik, and A. Tropsha Predicted QSAR modeling J Comp Aided Mol Des 16 2002 357 369
133. R.P. Sheridan, B.P. Feuston, V.N. Maiorov, and S.K. Kearsley Similarity to molecules in training set is a good descriminator for prediction accuracy in QSAR J Chem Inf Comput Sci 44 2004 1912 1928
134. D.G. Sprous Fingerprint-based clustering applied to define a QSAR model use radius J Mol Graph Mod 27 2008 225 232
135. J. Van Drie Pharmacophore discovery: a critical review P. Bultinck, H. Winter, W. Langenaeker, J. Tollenare, Computational medicinal chemistry for drug discovery 2004 Marcel Dekker New York 437 461
136. D.G. Sprous, R.K. Palmer, J.T. Swanson, and M. Lawless QSAR in the pharmaceutical research setting: QSAR models for broad large problems Curr Top Med Chem 2010 (accepted)
137. O. Guner Pharmacophore perception, development, and use in drug design 2000 International University Line La Jolla, CA, USA
138. Y. Langer, and R.D. Hoffman Pharmacophore and pharmacophore searches 2006 Wiley VCH Velag GmbH & Co. KgaA Weinheim, Germany
139. Discovery-Studio. Accelrys Inc.: San Diego, CA, USA
140. Phase. Shrodinger Inc.: New York, NY, USA
141. MDDR. MDL Information Systems: San Leandro, CA
142. Aureus Biopharma. Paris, France
143. GVK BIO. Hyperabad, India
144. ZINC. University of California, San Francisco: San Francisco, CA, USA
145. ACD. Symyx Corporation: Sunnyvale, CA, USA
146. CAP. Accelrys Inc.: San Diego, CA, USA
147. Asinex Inc.: Moscow, Russia
148. ChemBridge Inc.: Moscow, Russia
149. ChemDiv Inc.: Moscow, Russia
150. Enamine Inc.: Kiev, The Ukraine
151. BS Inc.: Moscow, Russia
152. Maybridge Tintagel: Cornwall, UK
153. LifeChem.Inc.: Kiev, The Ukraine
154. Otava Inc.: Kiev, The Ukraine
155. Pharmeks Inc.: Moscow, Russia
156. Vitas Inc.: Moscow, Russia
157. N. Baurin, R. Baker, C. Richardson, I. Chen, N. Foloppe, and A. Potter Drug like annotation and duplicate analysis of a 23 supplier chemical database totaling 2.7 M compounds J Chem Inf Comp Sci 44 2004 643 651
158. A. Tropsha, and C.H. Reynolds Designing focused libraries for drug discovery J Mol Graph Mod 20 2002 427 428
159. M.M. Olah, C.G. Bologna, and T.I. Oprea Strategies for compound selection Curr Drug Disc Tech 1 2004 211 220
160. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Adv Drug Deliv Rev 23 1997 3 26
161. T.I. Oprea, A.M. Davis, S.J. Teague, and P.D. Keeson Is there a difference between leads and drugs J Chem Inf Comput Sci 41 2001 1308
162. M.M. Hahn, and T.I. Oprea Pursuing the leadlikeness concept in pharmaceutical research Curr Opin Chem Biol 8 2004 255 263
163. J. Seidler, S.L. McGovern, T.N. Doman, and B.K. Schoichet Identification and prediction of promiscuous aggregating inhibitors among known drugs J Med Chem 2003 46 2003 4477 4486 (Pubitemid 37238749)
164. Ajay, W.P. Walter, and M.A. Murcko Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J Med Chem 41 1998 3314 3324 (Pubitemid 28406538)
165. J. Sadowski, and H. Kubinyi A scoring scheme for discriminating between drugs and nondrugs J Med Chem 41 1998 3325 3329 (Pubitemid 28406539)
166. G.A. Burdock The GRAS process Food Tech 57 2003 17
167. L.A. Woods, and J. Doull GRAS evaluation of flavoring substances by the expert panel of FEMA Regul Toxicol Pharmacol 14 1991 48 58
168. Flavor-Base. Leffingwell & Associates: Canton Georgia (USA); 2004
169. D.G. Sprous, and F.R. Salemme A comparison of the chemical properties of drugs and GRAS compounds Food Chem Toxicol 45 2007 1419 1427
170. Prestwick Screening Library. Prestwick Chemical Company: Illkirch France
171. D.G. Sprous, P. Stein, F.R. Salemme, and R.K. Palmer Development of a GRAS-like screening library from commercial suppliers 2008 2008; [unpublished results]
172. M. Congreve, R. Carr, C. Murray, and H. Jhoti A rule-of-three for fragment based lead discovery Drug Discov Today 8 2003 876 877
173. P. Jimonet, and R. Jager Strategies for designing GPCR-focus libraries and screening sets Curr Opin Drug Discov Dev 7 2004 325 333 (Pubitemid 44111942)
174. F. Horn, J. Weare, M.W. Beukers, S. Horsch, A. Bairoch, and W. Chen GPCRDB: an information system for G protein-coupled receptors Nucleic Acids Res 26 1998 275 279 (Pubitemid 28295284)
175. G. Manning, D.B. Whyte, R. Martinez, and T. Hunter The protein kinase complement of the human genome Science 298 2002 1912 1934 (Pubitemid 35425239)
176. D.T. Manallack, W.R. Pitt, W. Gancia, J.G. Montana, D.T. Livingstone, and M.G. Ford Selecting screening candidates for kinase and GPCR targets using neural networks J Chem Inf Comput Sci 42 2002 1256 1262
177. F.R. Burden Molecular identification number for substructure searches J Chem Inf Comput Sci 29 1989 225 227
178. R.S. Pearlman, and K.M. Smith Metric evaluation and the receptor-relecant subspace concept J Chem Inf Comput Sci 39 1999 28 35
179. R.S. Pearlman, and K.M. Smith Novel software tools for molecular diversity Perspect Drug Discov Des 9 1998 339 353
180. K.V. Balakin, S.E. Tkachenko, S.A. Lang, I. Okun, A.A. Ivanshchenko, and N.P. Savchuk Property based design of GPCR targeted library J Chem Inf Comput Sci 42 2002 1332 1342
181. C. Rolland, R. Gozalbes, E. Nicolai, M.F. Paugam, L. Coussy, and F. Barbosa GPCR affinity predicted based on the use of a profiling dataset J Med Chem 48 2005 6563 6574
182. A. Givehchi, and G. Schneider Multispace classification for predicting GPCR ligands Mol Div 9 2005 371 383
183. T. Guo, and D.W. Hobbs Privileged structure-based combinatorial libraries targeting G protein-coupled receptors Assay Drug Dev Tech 1 2003 579 592
184. D.V. Vasilyev, Q.J. Shan, V. Soloveva, S.P. Nawoschik, E.J. Kaftan, and S.C. Mayer A novel HTS assay for HCN channel blockers using membrane potential sensitive dye and FLIPR J Biomol Screen 14 2009 1119 1128
185. W. Haverkamp, G. Breithardt, A.J. Camm, M.J. Janse, M.R. Rosen, and C. Antzelevitch The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs Cardiovasc Res 47 2000 219 233
186. F. De Ponti, E. Poluzzi, and N. Montanaro QT-interval prolongation by non-cardiac drugs Eur J Clin Pharmacol 56 2000 1 18
187. W.S. Redfern, L. Carlsson, A.S. Davis, W.G. Lynch, I. MacKenzie, and S. Palethorpe Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs Cardiovasc Res 58 2003 32 45
188. S. Neher, and B. Sakmann The patch clamp technique Sci Am 266 1992 44 51
189. C. Wood, C. Williams, and G.J. Waldron Patch clamping by numbers Drug Discov Today 9 2004 434 441 (Pubitemid 38510562)
190. K. Hansen, F. Rathke, T. Schroeter, G. Rast, T. Fox, and J.M. Kriegl Bias-correction of regression models: a case study of hERG inhibition J Chem Inf Mod 49 2009 1486 1496
191. S.R. Johnson, H. Yue, M.L. Conder, H. Shi, A.M. Doweyko, and J. Lloyd Estimation of hERG inhibition of drug candidates using multivariant property and pharmacophore SAR Bioorg Med Chem 15 2007 6182 6192 (Pubitemid 47088957)
192. S. Polak, B. Wisniowska, and J. Brandys Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs cardiotoxic properties J Appl Toxicol 29 2009 183 206
193. D.J. Diller, and D.W. Hobbs Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation J Comput Aided Mol Des 21 2007 379 393
194. S. Ekins, W.J. Crumb, R. Dustan-Sarazan, J.H. Wikel, and S.A. Wrighton Three dimensional quantitative structure activity relationship for inhibition of human ether-a-go-go-related gene potassium channel J Pharm Exp Therap 301 2002 427 434 (Pubitemid 34429951)
195. M. Song, and M. Clark Development and evaluation of an in-silico model for hERG binding J Chem Inf Model 46 2006 392 400 (Pubitemid 43282130)
196. K.M. Thai, and G.F. Eckert A binary QSAR model for classification of hERG potassium channel blockers Bioorg Med Chem 16 2008 4107 4119
197. S.S. Schiffman, B.J. Booth, B.T. Carr, M.L. Losee, E.A. Sattely-Miller, and B.G. Graham Investigation of synergism of binary mixtures of sweeteners Brain Res Bull 38 1994 105 120
198. Biofocus: Saffron, Walden, UK
199. Eskitis Institute: Brisbane, Queensland, Australia
200. Phytomyco Research Corporation: Greenville, NC, USA
201. Magellan Biosciences Group, Inc.: Tampa, FL, USA
202. Albany Molecular: Albany, NY, USA
203. D.G. Sprous, P. Stein, F.R. Salemme, and R.K. Palmer Internal RedPoint Bio review of natural product suppliers 2007 2007; [unpublished data]
204. A. Gomtsyan, E.K. Bayburt, R.G. Schmidt, C.S. Surowy, P. Honore, and K.C. Marsh Identification of (R)-1-(5-tert-butyl-2, 3-dihydro-1H-inden-1-yl)-3-(1H- indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management J Med Chem 51 2008 392 395 (Pubitemid 351252266)
205. L.M. Broad, S.J. Keding, and M.J. Blanco Recent progress in the development of selective TRPV1 antagonists for pain Curr Top Med Chem 8 2008 1431 1441
206. C.A. Blum, X. Zheng, H. Brielmann, K.J. Hodgetts, R. Bakthavatchalam, and J. Chandrasekhar Aminoquinazolines as TRPV1 antagonists: modulation of druglike properties through the exploration of 2-position substitution Bioorg Med Chem Lett 18 2008 4573 4577
207. E.M. Doherty, C. Fotsch, A.W. Bannon, Y. Bo, N. Chen, and C. Dominguez Novel vanilloid receptor-1 antagonists. 2. Structureactivity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate J Med Chem 50 2007 3515 3527 (Pubitemid 47195460)
208. J.D. Pomonis, J.E. Harrison, L. Mark, D.R. Bristol, K.J. Valenzano, and K. Walker N-(4-tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine- 1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties. II. In vivo characterization in rat models of inflammatory and neuropathic pain J Pharmacol Exp Ther 306 2003 387 393 (Pubitemid 36734396)
209. P.R. Kym, M.E. Kort, and C.W. Hutchins Analgesic potential of TRPV1 antagonists Biochem Pharmacol 78 2009 211 216
210. W.S. Cheung, R.R. Calvo, B.A. Tounge, S.P. Zhang, D.R. Stone, and M.R. Brandt Discovery of piperidine carboxamide TRPV1 antagonists Bioorg Med Chem Lett 18 2008 4569 4572